No. of employees decline sharply due to restructuring/reorgs

By | translator Alice Kang

22.04.11 06:00:42

가나다라 0

Over 200 jobs cut back in 4 companies – Sanofi, Roche, Lilly, and Zuellig

Underwent large-scale restructurings due to split-offs and business withdrawals

Main target were the sales division employees due to preference for online sales activities from COVID-19

The number of employees at multinational pharmaceutical companies has declined sharply due to their active restructuring and reorganizations. Over 200 employees have been laid off in just 4 companies - Roche Korea, Lilly Korea, Sanofi-Aventis Korea, and Zuellig Pharma Korea.

According to the Financial Supervisory Service, the number of employees at Roche Korea, Lilly Korea, Sanofi-Aventis Korea, and Zuellig Pharma Korea was 1,109, which was a 16% decrease from the 1,326 of the previous year.

Approximately 80 employees left Sanofi-Aventis Korea last year. The number of employees in the company had been 492 at the end of 2020 but was reduced to 413. In the same period, the numbe

(same@dailypharm.com)

If you want to see the full article, please JOIN US (click)